mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
RDEA119 |
FIMM |
pan-cancer |
AAC |
-0.35 |
0.05 |